13-48707314-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001308476.3(CYSLTR2):āc.497T>Cā(p.Ile166Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000112 in 1,613,946 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001308476.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CYSLTR2 | NM_001308476.3 | c.497T>C | p.Ile166Thr | missense_variant | 5/5 | ENST00000682523.1 | NP_001295405.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CYSLTR2 | ENST00000682523.1 | c.497T>C | p.Ile166Thr | missense_variant | 5/5 | NM_001308476.3 | ENSP00000508181.1 | |||
CYSLTR2 | ENST00000614739.4 | c.497T>C | p.Ile166Thr | missense_variant | 5/5 | 1 | ENSP00000477930.1 | |||
CYSLTR2 | ENST00000282018.4 | c.497T>C | p.Ile166Thr | missense_variant | 1/1 | 6 | ENSP00000282018.3 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152182Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000598 AC: 15AN: 250666Hom.: 0 AF XY: 0.0000443 AC XY: 6AN XY: 135454
GnomAD4 exome AF: 0.0000116 AC: 17AN: 1461764Hom.: 0 Cov.: 31 AF XY: 0.0000110 AC XY: 8AN XY: 727208
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152182Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74350
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 13, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at